8 unchanged sentences
There was no change in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the quarter ended December 31, 2024 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
−Removed: As we are no longer an emerging growth company and adapted our system of internal controls over financial reporting pursuant to Section 404(a) of the Sarbanes-Oxley Act, we did not identify any material weakness in our internal control over financing reporting at December 31, 2023.
+Added: As we are no longer an emerging growth company and adapted our system of internal controls over financial reporting pursuant to Section 404(a) of the Sarbanes-Oxley Act, we did not identify any material weakness in our internal control over financial reporting at December 31, 2024.
Management’s Report on Internal Control over Financial Reporting and Attestation Report of the Registered Public Accounting Firm
4 unchanged sentences
Other Information
−Removed: During the fiscal quarter ended December 31, 2023, none of our officers or directors, as defined in Rule 16 a -1 (f), adopted, modified or terminated a "Rule 10 b5-1 trading arrangement" or a "non-Rule 10b5-1 trading arrangement," as those terms are defined in Item 408 of Regulation S-K.
+Added: During the fiscal quarter ended December 31, 2024, none of our officers or directors, as defined in Rule 16a-1(f), ado pted , modi fied or termi nated a "Rule 10b5-1 trading arrangement" or a "non-Rule 10b5-1 trading arrangement," as those terms are defined in Item 408 of Regulation S-K.
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
27 unchanged sentences
001-37717) filed on October 26, 2020).
+Added: Certificate of Amendment to Amended and Restated Certificate of Incorporation of Senseonics Holdings, Inc.
+Added: (incorporated herein by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No.
+Added: 001-37717), filed with the Commission on May 22, 2024).
Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No.
7 unchanged sentences
001-37717) filed on March 5, 2021).
−Removed: Indenture, dated July 25, 2019, between the Registrant and U.S.
−Removed: Bank National Association, as Trustee (incorporated by reference to Exhibit 4.1 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-37717) filed on July 29, 2019).
−Removed: Form of Note representing the Company’s 5.25% Convertible Senior Notes due 2025 (incorporated by reference to Exhibit 4.2 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-37717), filed with the Commission on July 29, 2019).
−Removed: Registration Rights Agreement, dated as of July 25, 2019, by and among the Company, the Subsidiary and Jefferies LLC (incorporated herein by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-37717), filed with the Commission on July 29, 2019).
Registration Rights Agreement, dated as of August 9, 2020, by and between the Registrant and PHC Holding Corporation (incorporated herein by reference to Exhibit 4.1 to Amendment No.
1 unchanged sentence
001-37717), filed with the Commission on August 31, 2020).
−Removed: Description of Document
Investor Rights Agreement, dated as of August 9, 2020, by and between the Registrant and PHC Holding Corporation (incorporated herein by reference to Exhibit 4.3 to Amendment No.
2 unchanged sentences
Description of Senseonics Holdings, Inc.
−Removed: Common Stock (incorporated by reference to Exhibit 4.7 to the Registrant’s Annual Report on Form 10-K (File No.
−Removed: 001-37717) filed on March 16, 2020).
+Added: Description of Document
Registration Rights Agreement, by and between Senseonics Holdings, Inc.
30 unchanged sentences
333-198168) filed on December 10, 2015).
−Removed: Description of Document
Form of 2016 Employee Stock Purchase Plan (incorporated by reference to Exhibit 4.10 to the Registrant’s Registration Statement on Form S-8 (File No.
2 unchanged sentences
001-37717) filed on August 9, 2016) .
+Added: Description of Document
Senseonics Holdings, Inc.
14 unchanged sentences
001-37717) filed with the Commission on August 9, 2022).
+Added: Third Amendment to Collaboration and Commercialization Agreement, by and between the Subsidiary and Ascensia Diabetes Care Holdings AG, dated as of April 1, 2024 (incorporated herein by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q (File No.
+Added: 001-37717) filed with the Commission on August 8, 2024).
2023 Commercial Equity Plan, dated as of January 10, 2023 (incorporated herein by reference to Exhibit 4.1 to the Registration Statement on Form S-3 (File No.
12 unchanged sentences
001-37717) filed with the Commission on March 15, 2023).
+Added: Securities Purchase Agreement dated October 24, 2024 between Senseonics Holdings, Inc.
+Added: and the purchasers party thereto.
+Added: (incorporated herein by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No.
+Added: 001-37717), filed with the Commission on October 28, 2024).
Non-Employee Director Compensation Policy (As amended on May 25, 2021) (incorporated herein by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q (File No.
001-37717) filed with the Commission on May 9, 2023).
+Added: Description of Document
Loan and Security Agreement, dated September 8, 2023, by and among the Company and Hercules Capital, Inc.
1 unchanged sentence
001-37717) filed with the Commission on September 11, 2023).
−Removed: Description of Document
Form of Warrant Agreement (incorporated herein by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K (File No.
001-37717) filed with the Commission on September 11, 2023).
−Removed: L etter from Ernst & Young LLP dated March 15, 2022 to the Securities and Exchange Commission regarding change in certifying accountant (incorporated herein by reference to Exhibit 16.1 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-37717) filed with the Commission on March 15, 2022).
+Added: Form of Common Stock Purchase Warrant (incorporated by reference to Exhibit 4.1 to the Registrant’s Current Report on Form -K (File No.
+Added: 001-37717) filed with the Commission on October 28, 2024).
+Added: Insider Trading Policy
Subsidiaries of the Registrant (incorporated by reference to Exhibit 21.1 to the Registrant's Current Report on Form 8-K (File No.
5 unchanged sentences
Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: Incentive Compensation Recoupment Policy, approved October 25, 2023.
+Added: Incentive Compensation Recoupment Policy, approved October 25, 2023, incorporated by reference to Exhibit 97.1 of the Registrant’s Current Report on Form 10-K filed with the SEC on March 1, 2024 .
XBRL Instance Document
18 unchanged sentences
President and Chief Executive Officer
−Removed: February 29, 2024
+Added: March 3, 2025
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Timothy T.
4 unchanged sentences
President, Chief Executive Officer and Director
−Removed: February 29, 2024
+Added: March 3, 2025
Goodnow, Ph.D.
2 unchanged sentences
Chief Financial Officer
−Removed: February 29, 2024
+Added: March 3, 2025
Rick Sullivan
2 unchanged sentences
Chairman of the Board of Directors
−Removed: February 29, 2024
+Added: March 3, 2025
/s/ Steven Edelman, M.D.
−Removed: February 29, 2024
+Added: March 3, 2025
Steven Edelman, M.D.
/s/ Edward J.
−Removed: February 29, 2024
+Added: March 3, 2025
/s/ Douglas S.
−Removed: February 29, 2024
+Added: March 3, 2025
/s/ Douglas A.
−Removed: February 29, 2024
+Added: March 3, 2025
/s/ FRANCINE KAUFMAN, M.D.
Director and Chief Medical Officer
−Removed: February 29, 2024
+Added: March 3, 2025
Francine Kaufman, M.D.
−Removed: /s/ ROBERT SCHUMM
−Removed: February 29, 2024
−Removed: Robert Schumm
−Removed: /s/ ANTHONY RAAB
−Removed: February 29, 2024
+Added: /s/ SHARON D.
+Added: March 3, 2025
/s/ koichiro sato
−Removed: February 29, 2024
+Added: March 3, 2025
Koichiro Sato
−Removed: /s/ SHARON D.
−Removed: February 29, 2024
+Added: /s/ BRIAN HANSEN
+Added: March 3, 2025
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.